Does the specialty of the surgeon performing elective anterior/lateral lumbar interbody fusion for degenerative spine disease correlate with early perioperative …

S Alomari, JL Porras, SFL Lo, N Theodore… - World neurosurgery, 2021 - Elsevier
World neurosurgery, 2021Elsevier
Background Comparative effectiveness research has a vital role in health reform and
policies. Specialty training is one of these provider-side variables, and surgeons performing
the same procedure who were trained in different specialties may have different outcomes.
The objective of this study was to investigate the impact of spine surgeon specialty
(neurosurgery vs. orthopedic surgery) on early perioperative outcome measures of elective
anterior/lateral lumbar interbody fusion (ALIF/LLIF) for degenerative disc diseases. Methods …
Background
Comparative effectiveness research has a vital role in health reform and policies. Specialty training is one of these provider-side variables, and surgeons performing the same procedure who were trained in different specialties may have different outcomes. The objective of this study was to investigate the impact of spine surgeon specialty (neurosurgery vs. orthopedic surgery) on early perioperative outcome measures of elective anterior/lateral lumbar interbody fusion (ALIF/LLIF) for degenerative disc diseases.
Methods
In a retrospective, 1:1 propensity score–matched cohort study, 9070 patients were reviewed from the American College of Surgeons National Surgical Quality Improvement Program database. Propensity score matching and subgroup analysis were used.
Results
In both groups (single-level and multilevel ALIF/LLIF), patients operated on by neurosurgeons had longer operative time (188 minutes vs. 172 minutes/239 minutes vs. 221 minutes); shorter total hospital stay (71 hours vs. 90 hours/89 hours vs. 96 hours); and lower rates of return to the operating room (2.1% vs. 4.1%/2.4% vs. 4.2%), nonhome discharge (8.7% vs. 11.1%/10.1% vs. 14.9%), discharge after postoperative day 3 (22.0% vs. 30.0%/38.0% vs. 43.9%), and perioperative blood transfusion (2.1% vs. 5.1%/5.0% vs. 9.9%) (P < 0.05). In multilevel ALIF/LLIF, patients operated on by neurosurgeons had lower readmission rates (3.9% vs. 6.9%) (P < 0.05). Other outcome measures and mortality rates were similar between the single-level and multilevel ALIF/LLIF cohorts regardless of surgeon specialty.
Conclusions
Our analysis found significant differences in early perioperative outcomes of patients undergoing ALIF/LLIF by neurosurgeons and orthopedic surgeons. These differences have significant clinical and cost implications for patients, physicians, program directors, payers, and health systems.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果